Organigram Holdings (Nasdaq: OGI) is one of the latest big-name companies to focus on building up its arsenal of hemp ...

A lesser-known cannabinoid that is gaining in popularity, Cannabigerol (CBG), effectively reduced anxiety in a clinical trial without the intoxication typically associated with whole plant cannabis.

The move to provide more low-dose products allows companies to access new market demographics, such as inexperienced cannabis ...

These formulations were developed though our Canadian R&D platform and manufactured through South American operations with ...

(“Vantage” or “the Company”), a globally accredited cannabinoid extractor and manufacturer, announces the commercial launch of its pharmaceutical-grade CBG (cannabigerol) isolate. This new ...

July 31, 2024 — A lesser-known cannabinoid that is gaining in popularity Cannabigerol (CBG) effectively reduced anxiety in a clinical trial without the intoxication typically associated with ...

TORONTO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading lifestyle and consumer packaged ...